Skip to content

Allogenic Blood Transfusion During Elective Open Abdominal Aortic Surgery

Allogenic Blood Transfusion During Elective Open Abdominal Aortic Surgery and Its Predictors: a Retrospective Database Study at a Tertiary Hospital in Croatia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03891303
Enrollment
426
Registered
2019-03-27
Start date
2011-01-01
Completion date
2018-10-15
Last updated
2019-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Transfusion

Keywords

Aorta, abdominal, Intraoperative blood salvage, Elective surgical procedures, Patient outcomes assessment

Brief summary

Open surgery on the abdominal aorta is a high risk procedure associated with an intravascular volume blood loss and thereby, with high requirement for blood and blood product transfusion. The aim of this study was to establish the rate for allogenic blood transfusion (ABT) during elective open abdominal aortic surgery and find parameters associated with ABT requirements.

Detailed description

Two distinct clinical entities affect the abdominal aorta: abdominal aortic aneurysm (AAA) and aortoiliac occlusive disease (AIOD). These are multifactorial vascular disorders caused by complex genetic and environmental factors. Older patients with more comorbidity are often affected. Open abdominal aortic surgery is associated with high mortality rate. Even in specialised institutions it varies from 2 to 5%. Similar results can be compared to mortality for coronary artery bypass grafting. This reflects the complexity of the surgery and the general health of those patients. It is associated with intravascular volume blood loss and, thereby, with a high requirement for blood and blood products transfusion. Allogenic blood transfusion (ABT) has been associated with an increased risk of tumour recurrence, postoperative infection, acute lung injury, perioperative myocardial infarction, postoperative low-output cardiac failure, and increased mortality. In the last decades, multiple strategies have been undertaken to prevent massive intraoperative blood loss during elective surgery and allogenic blood transfusion requirement. One of the method advocates a preoperative increase in red blood cells level using B12, folic acid and iron supplements or with erythropoietin usage. Other methods involve the optimisation of surgical technique and the use of a machine for intraoperative blood salvage, known as cell saver. The aim of this study was to establish the rate for ABT during elective open abdominal aortic surgery, find parameters associated with ABT requirements, and optimise the investigators hospital's maximum surgical blood ordering schedule (MSBOS).

Interventions

OTHERAllogenic blood transfusion (ABT)

During elective open aortic surgery, the autologous blood from ICS was processed and re-transfused in all patients. However, TR group additionally received ABT.

Sponsors

Clinic for Cardiovascular Diseases Magdalena
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients older than 18 years * Elective open abdominal aortic surgery * Abdominal aortic aneurysm repair * Abdominal aortic bypass grafting for occlusive aortoiliac disease

Exclusion criteria

* Patients younger than 18 years * Patients undergoing cardiac surgery * Patients with ruptured abdominal aneurysms * Patients undergoing endovascular aortic repair * Patients submitted to other types of vascular surgery (i.e., carotid endarterectomy or peripheral bypass surgery)

Design outcomes

Primary

MeasureTime frameDescription
Overall ABT requirementRetrospective analysis, 6-year periodOverall ABT requirement (in %) during elective abdominal aortic surgery with the use of ICS for intraoperative blood salvage and autologous transfusion.

Secondary

MeasureTime frameDescription
Gender as the predictors of higher ABT requirementRetrospective analysis, 6-year periodmale/female
Body mass index (BMI) as the predictors of higher ABT requirementRetrospective analysis, 6-year periodBMI (kg/m2)
Body surface area (BSA) as the predictors of higher ABT requirementRetrospective analysis, 6-year periodBSA (m²)
Total blood volume as the possible predictors of higher ABT requirementRetrospective analysis, 6-year periodTBV (in liters) calculated trough Nadler's formula
Hemoglobin (Hb) and hematocrit (Htc) as the predictors of higher ABT requirementRetrospective analysis, 6-year periodHb (g/L) and Htc (%)
Age as the predictor of higher ABT requirementRetrospective analysis, 6-year period(years)
Patient's comorbidities as the predictors of higher ABT requirementRetrospective analysis, 6-year periodarterial hypertension, coronary artery disease, diabetes, atrial fibrillation, cerebrovascular incidents, chronic obstructive pulmonary disease, chronic renal insufficiency, malignancy
Medications that impair coagulation and homeostasis as the predictor of higher ABT requirementRetrospective analysis, 6-year periodacetylsalicylic acid, clopidogrel, or warfarin
Postoperative duration of mechanical ventilationRetrospective analysis, 6-year period(hours)
Length of stay (LOS)Retrospective analysis, 6-year periodLOS in ICU (days) and overall hospital LOS (days)
In-hospital mortality rateRetrospective analysis, 6-year period(in %)
Type of illness as the predictor of higher ABT requirementRetrospective analysis, 6-year periodabdominal aortic aneurysm or aortoiliac occlusive disease

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026